Found: 28
Select item for more details and to access through your institution.
Dispensing pharmacy chains and direct anticoagulants: Potential associations with patient outcomes.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 2, p. 1, doi. 10.1002/pds.5749
- By:
- Publication type:
- Article
Biosimilar Uptake in Medicare Advantage vs Traditional Medicare.
- Published in:
- JAMA Health Forum, 2023, v. 4, n. 12, p. e234335, doi. 10.1001/jamahealthforum.2023.4335
- By:
- Publication type:
- Article
THE JANUARY ANOMALY AND ANOMALIES IN JANUARY.
- Published in:
- Applied Finance Letters, 2023, v. 12, n. 1, p. 2, doi. 10.24135/afl.v12i1.615
- By:
- Publication type:
- Article
Uptake and Competition Among Biosimilar Biological Products in the US Medicare Fee-for-Service Population.
- Published in:
- JGIM: Journal of General Internal Medicine, 2022, v. 37, n. 16, p. 4292, doi. 10.1007/s11606-022-07670-7
- By:
- Publication type:
- Article
A novel murine in vivo model for acute hereditary angioedema attacks.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-95125-0
- By:
- Publication type:
- Article
Entrenchment or efficiency? CEO‐to‐employee pay ratio and the cost of debt.
- Published in:
- Financial Review, 2021, v. 56, n. 3, p. 511, doi. 10.1111/fire.12256
- By:
- Publication type:
- Article
Early antibody responses associated with survival in COVID19 patients.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 7, p. 1, doi. 10.1371/journal.ppat.1009766
- By:
- Publication type:
- Article
Uptake and Usage Patterns of Biosimilar Infliximab in the Medicare Population.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Share‐pledging and the cost of debt.
- Published in:
- Accounting & Finance, 2021, v. 61, n. 1, p. 1047, doi. 10.1111/acfi.12603
- By:
- Publication type:
- Article
Healthy User Bias in Comparative Safety Studies for Brand‐Name vs. Generic Products: The Example of Warfarin.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 5, p. 1037, doi. 10.1002/cpt.1498
- By:
- Publication type:
- Article
Uptake of the Biologic Filgrastim and Its Biosimilar Product Among the Medicare Population.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service Medicare.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Precision and robustness of 2D-NMR for structure assessment of filgrastim biosimilars.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 2, p. 139, doi. 10.1038/nbt.3474
- By:
- Publication type:
- Article
Advancing Product Quality: a Summary of the Inaugural FDA/PQRI Conference.
- Published in:
- 2015
- By:
- Publication type:
- Report
Oversulfated Chondroitin Sulfate Binds to Chemokines and Inhibits Stromal Cell-Derived Factor-1 Mediated Signaling in Activated T Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0094402
- By:
- Publication type:
- Article
Polyreactive Antibodies Plus Complement Enhance the Phagocytosis of Cells Made Apoptotic by UV-Light or HIV.
- Published in:
- Scientific Reports, 2013, p. 1, doi. 10.1038/srep02271
- By:
- Publication type:
- Article
Oversulfated Chondroitin Sulfate Inhibits the Complement Classical Pathway by Potentiating C1 Inhibitor.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0047296
- By:
- Publication type:
- Article
Complement C1 Esterase Inhibitor Levels Linked to Infections and Contaminated Heparin-Associated Adverse Events.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0034978
- By:
- Publication type:
- Article
Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2010, v. 19, n. 9, p. 921, doi. 10.1002/pds.1991
- By:
- Publication type:
- Article
Hurdles and Leaps for Protein Therapeutics.
- Published in:
- Annals of the New York Academy of Sciences, 2009, v. 1182, n. 1, p. 146, doi. 10.1111/j.1749-6632.2009.05158.x
- By:
- Publication type:
- Article
Role of {alpha}3 domain of class I MHC molecules in the activation of high- and low-avidity CD8+ CTLs.
- Published in:
- International Immunology, 2007, v. 19, n. 12, p. 1413, doi. 10.1093/intimm/dxm111
- By:
- Publication type:
- Article
The FDA's assessment of follow-on protein products: a historical perspective.
- Published in:
- 2007
- By:
- Publication type:
- review
Peptide immunization excludes antigen-specific T cells from splenic lymphoid compartments.
- Published in:
- European Journal of Immunology, 2005, v. 35, n. 3, p. 776, doi. 10.1002/eji.200425479
- By:
- Publication type:
- Article
ICAM-1 enhances MHC-peptide activation of CD8.
- Published in:
- European Journal of Immunology, 2000, v. 30, n. 11, p. 3266, doi. 10.1002/1521-4141(200011)30:11<3266::AID-IMMU3266>3.0.CO;2-F
- By:
- Publication type:
- Article
ICAM-1 co-stimulation has differential effects on the activation of CD4.
- Published in:
- European Journal of Immunology, 1999, v. 29, n. 3, p. 809, doi. 10.1002/(SICI)1521-4141(199903)29:03<809::AID-IMMU809>3.0.CO;2-X
- By:
- Publication type:
- Article
Naive alloreactive CD8 T cells are activated by purified major histocompatibility complex class I and antigenic peptide.
- Published in:
- European Journal of Immunology, 1997, v. 27, n. 4, p. 871, doi. 10.1002/eji.1830270411
- By:
- Publication type:
- Article
Functional cell surface expression by a recombinant single-chain class I major histocompatibility complex molecule with a cis-active β.
- Published in:
- European Journal of Immunology, 1994, v. 24, n. 11, p. 2633, doi. 10.1002/eji.1830241110
- By:
- Publication type:
- Article
AKR leukemia-specific surface antigens acquired by malignant transformation: Their common and individual specificities.
- Published in:
- International Journal of Cancer, 1976, v. 17, n. 5, p. 640, doi. 10.1002/ijc.2910170513
- By:
- Publication type:
- Article